Trials / Completed
CompletedNCT01232010
Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients
Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Male
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to investigate the effect of renal impairment on the safety and pharmacokinetics of SK3530 in subjects with renal impairment compared to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirodenafil | 50mg Single Oral Dose of |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2011-12-01
- First posted
- 2010-11-02
- Last updated
- 2015-01-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01232010. Inclusion in this directory is not an endorsement.